Main Article Content



To determine whether patients with chronic kidney disease (CKD) without dialysis their stage impacts the native vitamin D levels.


Patients over 18 years with chronic kidney disease stage 2-5 without dialysis treatment. They demographic, anthropometric variables, degree of sun exposure, disease etiology and laboratory variables related to bone and mineral disorders were evaluated. Study analytical cross-sectional prospective. Descriptive statistical methods for quantitative and qualitative are characterized, and analytical correlation between levels of vitamin D statistical laboratory tests related to bone and mineral disorders, sun exposure and ethnicity variables for each stage were characterized. By descriptive statistical methods, quantitative and qualitative variables were characterized, and analytical statistical correlation between levels of vitamin D with laboratory tests related to bone and mineral disorders, sun exposure and ethnicity for each stage were practiced.


331 patients were evaluated, with a mean age of 71 years, the mestizo majority (71%), 173 women, main etiology of CKD hypertensive nephropathy (33.2%). 21.1% of patients had normal levels of vitamin D, 70.1% insufficient, and 8.8% in deficit. Negative correlation was detected between the levels of vitamin 25(OH)D and serum creatinine, phosphorus, calcium x phosphorus product, PTH, proteins in urine 24 hours and BMI. Positive correlation for calcium and albumin. Positive statistical significance between the levels of vitamin 25(OH)D and sun exposure for 3b and 4 stages was found.


In patients with CKD is common to detect low levels of vitamin 25(OH)D, which can contribute to the generation of secondary hyperparathyroidism.


César Augusto Restrepo Valencia, Universidad de Caldas. Universidad de Manizales

Internista Nefrólogo, Profesor Asociado Universidad de Caldas. Profesor Asociado Universidad de Manizales

Jose Vicente Aguirre Arango, Universidad de Manizales

Salubrista Epidemiólogo Mg en Salud Publica. Profesor Catedrático Universidad de Manizales
Restrepo Valencia, C. A., & Aguirre Arango, J. V. (2016). Vitamin D (25 ( OH) D ) in patients with chronic kidney disease stages 2-5. Colombia Medica, 47(3), 160–66.

Melamed ML, Thadhani RI. Vitamin D therapy in chronic kidney disease and end stage renal disease. Clin J Am Soc Nephrol. 2012;7:358–365.

Chesney RW. Interactions of vitamin D and the proximal tubule. Pediatr Nephrol. 2016;31:7–14.

Bosworth C, de Boer IH. Impaired vitamin D metabolismo in CKD. Semin Nephrol. 2013;33:158–168.

Jacob AI, Sallman A, Santiz Z, Hollis BW. Defective photoproduction of cholecalciferol in normal and uremic humans. J Nutr. 1984;114:1313–1319.

Isakova T, Gutierrez OM, Patel NM, Andress DL, Wolf W, Levin A. Vitamin D deficiency, inflammation, and albuminuria in chronic kidney disease: complex interactions. J Ren Nutr. 2011;21:295–302.

Cankaya E, Bilen Y, Keles M, Uyanik A, Akbas M, Gungor A et al Comparison of Serum Vitamin D Levels Among Patients With Chronic Kidney Disease, Patients in Dialysis, and Renal Transplant Patients. Transplant Proc. 2015;47:1405–1407.

Engelen L, Schalkwijk CG, Eussen SJ, Sceijen JL, Soedamh-Muthu SS, Chaturvedi N, et al. Low 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 levels are independently associated with macroalbuminuria, but not with retinopathy and macrovascular disease in type 1 diabetes: the EURODIAB prospective complications study. Cardiovasc Diabetol. 2015;14:67–67.

Schmidt-Gayk H, Grawunder C, Tschope W, Schmitt W, Ritz E, Pietsch V, et al. 25-Hidroxy-Vitamin-D in nephrotic síndrome. Lancet. 1977;310:105–108.

Kumar J, McDermott K, Abraham AG, Aronson L, Friedman LA, Johnson VL, et al. Prevalence and correlates of 25-hydroxyvitamin D deficiency in the Chronic Kidney Disease in Children (CKiD) cohort. Pediatr Nephrol. 2016;31:121–129.

Hagenau T, Vest R, Gissel T N, Poulsen C S, Erlandsen M, Mosekilde L, et al. Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis. Osteoporos Int. 2009;20:133–140.

Del Valle E, Negri AL, Aguirre C, Fradinger E, Zanchetta JR. Prevalence of 25(OH)vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis. Hemodial Int. 2007;11:315–321.

Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S et al Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247–254.

KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Definition, identification, and prediction of CKD progression. Kidney Int. 2013;(3):63–72.

Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporos Int. 2005;16:713–716.

Dawson-Hughes B, Mithal A, Bonjour JP, Boonen S, Burckhardt P, Fuleihan GE, et al. IOF position statement: vitamin D recommendations for older adults. Osteoporos Int. 2010;21(7):1151–1151.

American Geriatrics Society Workgroup on Vitamin D Supplementation for Older Adults Recommendations abstracted from the American Geriatrics Society Consensus Statement on vitamin D for Prevention of Falls and Their Consequences. J Am Geriatr Soc. 2014;62:147–152.

Aspry TJ, Bowring C, Fraser W, Gittoes N, Javaid MK, Macdonald H, et al. National osteoporosis society vitamin D guideline summary. Age ageing. 2014;43:592–595.

Damasiewicz M, Kerr PG, Polkinghorne KR. Vitamina D therapy in chronic kidney disease: back to the future?. Clin. Nephrol. 2015;84:65–74.

Torregrosa JV, Bover J, Cannata J, Lorenzo V, de Francisco ALM, Martínez I, et al. Recomendaciones de la Sociedad Española de Nefrología para el manejo de las alteraciones del metabolismo óseo-mineral en los pacientes con enfermedad renal crónica (S.EE.N.- MM) Nefrologia. 2011;31(1):3–32.

Bellorin-Font E, Ambrosoni P, Carlini RG, Carvalho AB, Correa-Rotter R, Cueto-Manzano A, et al. Guías de práctica clínica para la prevención, diagnóstico, evaluación y tratamiento de los trastornos minerales y óseos en la enfermedad renal crónica (TMO-ERC) en adultos. Nefrologia. 2013;33(Suppl 1):1–28.

Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the dialysis outcomes and practice patterns study (DOPPS) Am J Kidney Dis. 2008;52:519–530.

Slinin Y, Foley RN, Collins AJ. Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1.3.and 4 study. J Am Soc Nephrol. 2005;16:1788–1793. (Ger).

Gutierrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med. 2008;359:584–592.

Levin A, Bakris G L, Molitch M, Smulders M, Tian J, Williams LA, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int. 2007;71:31–38.

Molina P, Gorriz JL, Molina MD, Peris A, Beltran S, Kanter J, et al. The effect of cholecalciferol for lowering albuminuria in chronic kidney disease: a prospective controlled study. Nephrol Dial Transplant. 2014;29:97–109.

Zhu N, Wang J, Gu L, Wang L, Yuan W. Vitamin supplements in chronic kidney disease. Ren Fail. 2015;37:917–924.

Witham MD, Nadir MA, Struthers AD. Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J. Hypertens. 2009;27:1948–1954.

Grandi NC, Breitling LP, Brenner H. Vitamin D and cardiovascular disease: systematic review and meta-analysis of prospective studies. Prev Med. 2010;51:228–233.

Durup D, Jørgensen HL, Christensen J, et al. ?Tjønneland A.Olsen A.Halkjær J A reverse J-Shaped association between serum 25-hydroxyvitamin D and cardiovascular disease mortality: the CopD Study. J Clin Endocrinol Metab. 2015;100:2339–2346.

Zhang Q, Jiang C, Sun C, Tang T, Jin B, Cao D, et al. Hypovitaminosis D is associated wit endotelial dysfunction in patients with non-dialysis chronic kidney disease. J Nephrol. 2015;28:471–476.

Grant WB. How strong is the evidence that solar ultraviolet B and vitamin D reduce the risk of cancer? an examination using Hill's criteria for causality. Dermatoendocrinol. 2009;1:17–24.

Badawi A, Sayegh S, Sadoun E, Al-Thani M, Arora P, Haddad PS. Relationship between insulin resistance and plasma vitamin D in adults. Diabetes Metab Syndr Obes. 2014;7:297–303.

Mitri J, Muraru MD, Pittas AG. Vitamin D and type 2 diabetes: a systematic review. Eur J Clin Nutr. 2011;65:1005–1015.

Peng Y, Li LJ. Serum 25-hydroxyvitamin D level and diabetic nephropathy in patients with type 2 diabetes mellitus. Int Urol Nephrol. 2015;47:983–989.

Zhang J, Zhang P, Ni X, Bao B, Huang C, Wu Y, et al. Vitamin D status in chonic dialysis patients with depression: a prospective study. BMC Psychiatry. 2014;14:125–125.

Lee Y, Kim J, Roh YH, Choi HR, Rhee Y, Kang DR, et al. The Combination of Vitamin D Deficiency and Mild to Moderate Chronic Kidney Disease Is Associated With Low Bone Mineral Density and Deteriorated Femoral Microarchitecture: Results From the KNHANES 2008 -2011. J Clin Endocrinol Metab. 2014;99:3879–3888.

Melamed ML, Michos ED, Post W, Astor B. 25- Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008;168:1629–1637.

Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008;168:1340–1349.

Weiner DE, Kapoian T, Johnson DS. Nutrition, vitamin D, and health outcomes in hemodialysis: time for a feeding frenzy? Curr Opin Nephrol Hypertens. 2015;24:546–556. [PubMed]

Kramer H, Berns JS, Choi MJ, Martin K, Rocco MV. 25-Hydroxyvitamin D testing and supplementation in CKD: an NKF-KDOQI controversies report. Am J Kidney Dis. 2014;64:499–509.

Kidney Disease:Improving Global Outcomes (KDIGO) CKD-MBD Work Group Clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD) Kidney Int Suppl. 2009;76:S1–130.

Cupisti A, Vigo V, Baronti ME, DÁlessandro C, Ghiadoni L, Egidi MF. Vitamin D status and cholecalciferol supplementation in chronic kidney disease patients: an Italian cohort report. International Journal of Nephrology and Renovascular Disease. 2015;8:151–157.

Parikh A, Chase HS, Vernocchi L, Stern L. Vitamin D resistance in chronic kidney disease (CKD) BMC Nephrology. 2014;15:47–47.

Junyu Z, Jianjun D, Haipeng W, Hongxia S, Dongmei Z, Lin L. Efficacy and safety of vitamin D3 in patients with diabetic nephropathy: a meta-analysis of randomized controlled trials. Chin Med J. 2014;127:2837–2843.

Humalda JK, Goldsmith DJ, Thadhani R, de Borst MH. Vitamin D analogues to target residual proteinuria: potential impact on cardiorenal outcomes. Nephrol Dial Transplant. 2015;30:1988–1994.


Download data is not yet available.
Received 2015-11-07
Accepted 2016-06-01
Published 2016-09-29